Abstract: A semiconductor device includes a semiconductor layer. A gate structure is disposed over the semiconductor layer. A spacer is disposed on a sidewall of the gate structure. A height of the spacer is greater than a height of the gate structure. A liner is disposed on the gate structure and on the spacer. The spacer and the liner have different material compositions.

Abstract: An electrochemical cell and battery system including cells, each cell including a catholyte, an anolyte, and a separator disposed between the catholyte and anolyte and that is permeable to the at least one ionic species (for example, a metal cation or the hydroxide ion). The catholyte solution includes a ferricyanide, permanganate, manganate, sulfur, and/or polysulfide compound, and the anolyte includes a sulfide and/or polysulfide compound. These electrochemical couples may be embodied in various physical architectures, including static (non-flowing) architectures or in flow battery (flowing) architectures.

Abstract: A device, method, and non-transitory computer readable storage medium for labelling motion data are provided. The device receives several motion signals, wherein each motion signal includes a motion time message and a motion data group. A motion script includes a plurality of preset motion messages, wherein each preset motion message includes a preset time message and a preset motion. The device performs the following steps for each preset time message: determining a first subset of the motion signals by comparing the motion time messages with the preset time message, calculating a similarity between the motion data group of each motion signal in the first subset and a reference model, determining a second subset of the first subset based on the first similarities, and labelling the motion data group of each motion signal included in the second subset as corresponding to the preset motion corresponding to the preset time message.

Abstract: A system for labeling motion data includes a memory and a processor. The memory stores instructions. The processor accesses and executes the instructions to perform the following: generate a motion trajectory passage, which includes an initial posture; access unlabeled motion data; determine whether the unlabeled motion data includes the initial posture; in response to the unlabeled motion data including the initial posture, determine whether the unlabeled motion data matches the motion trajectory passage; and in response to the unlabeled motion data matching the motion trajectory passage, attach a label to the unlabeled motion data.

Abstract: A device, method, and non-transitory computer readable storage medium for labelling motion data are provided. The device receives several motion signals, wherein each motion signal includes a motion time message and a motion data group. A motion script includes a plurality of preset motion messages, wherein each preset motion message includes a preset time message and a preset motion. The device performs the following steps for each preset time message: determining a first subset of the motion signals by comparing the motion time messages with the preset time message, calculating a similarity between the motion data group of each motion signal in the first subset and a reference model, determining a second subset of the first subset based on the first similarities, and labelling the motion data group of each motion signal included in the second subset as corresponding to the preset motion corresponding to the preset time message.

Abstract: An intelligent device is configured to provide relevant information related to an image. The intelligent device includes a sensor module, an activation module, an image capture module, an image recognition module, and an information providing module. The sensor module includes a magnetometer and a gyroscope. The magnetometer detects a direction of a gesture relative to the intelligent device. The gyroscope detects at least one angular velocity of the gesture. The activation module determines the gesture according to the direction and the angular velocities, and generates an activating signal according to the gesture determined. The image capture module captures the image according to the activation signal. The image recognition module identifies the image to retrieve relevant information related to the image. The information providing module provides the relevant information.

Abstract: An intelligent device is configured to provide relevant information related to an image. The intelligent device includes a sensor module, an activation module, an image capture module, an image recognition module, and an information providing module. The sensor module includes a magnetometer and a gyroscope. The magnetometer detects a direction of a gesture relative to the intelligent device. The gyroscope detects at least one angular velocity of the gesture. The activation module determines the gesture according to the direction and the angular velocities, and generates an activating signal according to the gesture determined. The image capture module captures the image according to the activation signal. The image recognition module identifies the image to retrieve relevant information related to the image. The information providing module provides the relevant information.

Abstract: A computer system is provided. The computer system includes multiple computing devices and a processing unit. The processing unit comprises a device monitoring module, a task classifying module and a task scheduling module. The processing unit is coupled to the computing devices. The device monitoring module is configured to monitor the computing devices so as to obtain loading data. The task classifying module is configured to classify related tasks of multiple tasks as a first group, to classify independent tasks of multiple tasks as a second group and to find a critical path of the related tasks in the first group. The task scheduling module is configured to set a first processing schedule of the first group according to the critical path and the loading data and to set a second processing schedule of the second group according to the first processing schedule.

Abstract: The invention provides isolated nucleic acids molecules and proteins, designated NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, and NARC 25, nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Abstract: The invention provides isolated nucleic acids molecules and proteins, designated 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 20A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Abstract: The invention provides isolated nucleic acids molecules and proteins, designated 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 20A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Abstract: The invention provides isolated nucleic acids molecules and proteins, designated 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Abstract: The invention provides isolated nucleic acids molecules and proteins, designated 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC 17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Abstract: The invention provides isolated nucleic acids molecules and proteins, designated 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC 17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Abstract: Novel programmed cell death-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length programmed cell death-related polypeptides, the invention further provides isolated programmed cell death-related fusion proteins, antigenic peptides, and anti-programmed cell death-related antibodies. The invention also provides programmed cell death-related nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a programmed cell death-related gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.

Abstract: The present invention relates to a newly identified human and mouse programmed cell death (PCD) protein having homology to mammalian subtilases. The invention also relates to polynucleotides encoding the protein. The invention further relates to methods using the polypeptides and polynucleotides as a target for diagnosis and treatment in disorders mediated by or related to the protein. The invention further relates to drug-screening methods using the polypeptides and polynucleotides to identify agonists and antagonists for diagnosis and treatment. The invention further encompasses agonists and antagonists based on the polypeptides and polynucleotides. The invention further relates to procedures for producing the polypeptides and polynucleotides.

Abstract: The invention provides isolated nucleic acids molecules, designated NARC8 nucleic acid molecules, which encode novel programmed cell death-associated proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing NARC8 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a NARC8 gene has been introduced or disrupted. The invention still further provides isolated NARC8 proteins, fusion proteins, antigenic peptides and anti-NARC8 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.